methylazoxymethanol acetate has been researched along with Disease Models, Animal in 146 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (3.42) | 18.7374 |
1990's | 14 (9.59) | 18.2507 |
2000's | 33 (22.60) | 29.6817 |
2010's | 72 (49.32) | 24.3611 |
2020's | 22 (15.07) | 2.80 |
Authors | Studies |
---|---|
Grace, AA; Sved, AF; Weeks, JJ | 1 |
Cash, D; Davies, C; Gomes, FV; Grace, AA; Kiemes, A; Modinos, G; Simmons, C; Singh, N; Stone, JM; Turkheimer, F; Uliana, DL; Vernon, AC | 1 |
An, Y; Lan, Y; Li, GY; Li, ML; Peng, Y | 1 |
D'Addario, C; Di Bartolomeo, M; Di Martino, S; Di Marzo, V; Drago, F; Iannotti, FA; Micale, V; Piscitelli, F; Ruda-Kucerova, J; Stark, T; Wotjak, CT | 1 |
Grace, AA; Zhu, X | 2 |
Boley, AM; Eassa, NE; Elam, HB; Lodge, DJ; McCoy, AM; Perez, SM | 1 |
Berta, B; Dusa, D; Gálosi, R; Kállai, V; Karádi, Z; Kertes, E; Kovács, A; László, K; Lénárd, L; Ollmann, T; Péczely, L; Tóth, A; Zagoracz, O | 1 |
Chen, GY; Chen, L; Cheng, Y; Du, Y; Li, XS | 1 |
Kopciuch, D; Kus, K; Murawiecka, P; Nowakowska, E; Paczkowska, A; Ratajczak, P; Słodzińska, I; Zaprutko, T | 1 |
Gzielo, K; Holuj, M; Litwa, E; Nikiforuk, A; Popik, P; Potasiewicz, A; Socha, L | 1 |
Babinska, Z; Bucolo, C; D'Addario, C; Di Bartolomeo, M; Di Marco, R; Di Marzo, V; Drago, F; Drazanova, E; Fedotova, J; Giurdanella, G; Iannotti, FA; Kratka, L; Mechoulam, R; Micale, V; Pekarik, V; Piscitelli, F; Platania, CBM; Ruda-Kucerova, J; Salomone, S; Starcuk, Z; Stark, T; Sulcova, A; Wotjak, CT | 1 |
Boley, AM; Carless, MA; Donegan, JJ; Glenn, JP; Lodge, DJ | 1 |
Babinska, Z; Hammer, T; Horska, K; Karpisek, M; Kotolova, H; Micale, V; Prochazka, J; Ruda-Kucerova, J; Stark, T | 1 |
Bienertova-Vasku, J; Horska, K; Hruska, P; Kucera, J; Kuruczova, D; Micale, V; Ruda-Kucerova, J | 1 |
Hu, LB; Huang, J; Ling, Y; Shen, HW; Xu, L; Zhang, XQ | 1 |
Grace, AA; Sonnenschein, SF | 2 |
Cabungcal, JH; Cuenod, M; Do, KQ; Grace, AA; Uliana, DL; Zhu, X | 1 |
Kim, EJ; Kim, MJ; Lee, M; Yum, MS | 1 |
Bilecki, W; Chmelova, M; Maćkowiak, M; Majcher-Maślanka, I; Wawrzczak-Bargieła, A | 1 |
Babinska, Z; Micale, V; Ruda-Kucerova, J; Stark, T | 1 |
Gálosi, R; Kállai, J; Kállai, V; Karádi, Z; László, K; Lénárd, L; Ollmann, T; Péczely, L; Petykó, Z; Szabó, I; Tóth, A | 1 |
Elefant, F; Gao, WJ; Gulchina, Y; Snyder, MA; Xu, SJ | 1 |
Alsiö, J; Bussey, TJ; Dourado, T; Gamallo-Lana, B; Lei, M; Mar, AC; Nilsson, SRO; Robbins, TW; Saksida, LM | 1 |
Gomes, FV; Grace, AA; Zhu, X | 1 |
Gill, KM; Grace, AA; Miller, SA | 1 |
Bator, E; Latusz, J; Maćkowiak, M; Wędzony, K | 1 |
Feng, GF; Hu, M; Li, CJ; Liu, JX; Liu, Y; Xu, JH; Yuan, B; Zhu, K | 1 |
Bator, E; Głowacka, U; Latusz, J; Maćkowiak, M; Mudlaff, K; Radaszkiewicz, A | 1 |
Azizi, M; Kashani, IR; Mokhtari, T; Nadji, SA; Omidi, N; Pasbakhsh, P; Pourabdollah, M; Sadr, M; Zendehdel, A | 1 |
Grace, AA; Neves, GA | 1 |
Edelson, JR; Gomes, FV; Grace, AA; Volk, DW | 1 |
Gao, WJ; Han, G; Snyder, MA; Wang, MJ; Xing, B | 1 |
Fenton, AA; Levy, ERJ; O'Reilly, KC; Patino, AV; Perica, MI | 1 |
Huang, H; Huo, C; Liu, X; Ye, H; Zhao, J; Zhao, T | 1 |
Gill, KM; Grace, AA; Sonnenschein, SF | 1 |
Aivaliotis, M; Chalkiadaki, K; Chatzaki, E; Kyriazidis, E; Sidiropoulou, K; Stavroulaki, V; Velli, A; Vouvoutsis, V | 1 |
Holuj, M; Nikiforuk, A; Piotrowska, D; Popik, P; Potasiewicz, A; Wojcik, M; Zajda, K | 1 |
Babinska, Z; Bari, M; D'Addario, C; Di Bartolomeo, M; Di Marco, R; Di Marzo, V; Drago, F; Drazanova, E; Giurdanella, G; Iannotti, FA; Maccarrone, M; Mechoulam, R; Micale, V; Pekarik, V; Piscitelli, F; Ruda-Kucerova, J; Salomone, S; Starcuk, Z; Stark, T; Sulcova, A; Wotjak, CT | 1 |
Donegan, JJ; Lodge, DJ; Perez, SM | 1 |
Lin, JR; Nakagawasai, O; Nemoto, W; Odaira, T; Onogi, H; Sakuma, W; Srivastava, LK; Takahashi, K; Tan-No, K | 1 |
Donny, EC; Grace, AA; Rupprecht, LE; Sved, AF; Weeks, JJ | 1 |
Drago, F; Drazanova, E; Kratka, L; Kuchar, M; Maryska, M; Micale, V; Ruda-Kucerova, J; Starcuk, Z; Stark, T | 1 |
Battaglia, GS; Cagnoli, C; Cipelletti, B; Colciaghi, F; de Curtis, M; Locatelli, D; Nobili, P; Zambon, S | 1 |
Lodge, DJ | 1 |
Abbah, J; Juliano, SL | 1 |
Guo, N; Kimura, R; Osumi, N; Suto, F; Yanagawa, Y; Yoshizaki, K | 1 |
Juliano, SL; Poluch, S | 1 |
Lodge, DJ; Perez, SM | 1 |
Abbah, J; Braga, MF; Juliano, SL | 1 |
Cook, JM; Gill, KM; Grace, AA; Poe, MM | 1 |
Chen, L; Lodge, DJ; Perez, SM | 2 |
Gill, KM; Grace, AA | 1 |
Carreno, FR; Frazer, A; Lodge, DJ; Perez, SM | 1 |
Chen, SH; Gean, PW; Hsiao, YH; Hung, HC | 1 |
Gomes, FV; Grace, AA; Guimarães, FS | 1 |
Allen, P; Grace, AA; McGuire, P; Modinos, G | 1 |
Jellett, AP; Jenks, K; Lucas, M; Scott, RC | 1 |
Bannerman, DM; Gastambide, F; Janhunen, SK; Karjalainen, M; Palmer, C; Svard, H; Taylor, AM; Tricklebank, M | 1 |
Goda, SA; Hunt, MJ; Kasicki, S; Olszewski, M; Piasecka, J; Rejniak, K; Whittington, MA | 1 |
Bellinger, SA; Kleven, GA | 1 |
Gálosi, R; Kállai, J; Kállai, V; Karádi, Z; Lénárd, L; Petykó, Z; Szabó, I; Tóth, A | 1 |
Howe, WM; Kozak, R; Oomen, C; Tierney, PL; Young, DA | 1 |
Aguilar, DD; Carless, MA; Giuffrida, A; Lodge, DJ; Neary, JL; Perez, SM | 1 |
Bator, E; Latusz, J; Maćkowiak, M; Radaszkiewicz, A; Wędzony, K | 1 |
Giermaziak, W; Kus, K; Murawiecka, P; Nowakowska, E; Ratajczak, P; Słodzińska, I | 1 |
Grace, AA | 1 |
Du, Y; Grace, AA | 2 |
Amchova, P; Babinska, Z; Drago, F; Micale, V; Ruda-Kucerova, J; Stark, T; Sulcova, A | 1 |
Gomes, FV; Grace, AA; Rincón-Cortés, M | 1 |
Coman, D; de Graaf, RA; Groman, SM; Herman, P; Hyder, F; Jiang, L; Kaneko, G; Rao, J; Rich, K; Sanganahalli, BG; Taylor, JR; Wang, H | 1 |
Fenton, AA; O'Reilly, KC; Perica, MI | 1 |
Akbari, M; Beyer, C; Eqlimi, E; Mortezaee, K; Omidi, A; Ragerdi Kashani, I; Zendedel, A | 1 |
Babinska, Z; Carlo Altamura, A; Cremaschi, L; D'Addario, C; Dell'Osso, B; Di Bartolomeo, M; Drago, F; Maccarrone, M; Micale, V; Palazzo, M; Pucci, M; Stark, T; Sulcova, A | 1 |
Ferguson, BR; Gao, WJ; Gulchina, Y; Hu, XQ; Li, F; Li, ML; Li, YC; Monaco, SA; Xing, B | 1 |
Bártová, E; Dekker, FJ; Dražanová, E; Kašpárek, T; Komůrková, D; Kozubek, S; Krejčí, J; Legartová, S; Mechoulam, R; Micale, V; Rudá-Kučerová, J; Seiser, C; Štark, T; Šulcová, A; Szymanski, W; Večeřa, J; Weitzer, G | 1 |
Fan, QY; Fazio, V; Hallene, K; Janigro, D; Marchi, N; Ramakrishna, S | 1 |
Grace, AA; Lodge, DJ | 4 |
Kisby, G; Palmer, V; Spencer, PS | 1 |
Behrens, MM; Grace, AA; Lodge, DJ | 1 |
Chu, K; Jung, KH; Kang, KM; Kim, JH; Kim, M; Lee, SK; Lee, ST; Park, HK; Park, KI; Roh, JK | 1 |
Jay, TM; Krebs, MO; Le Pen, G | 1 |
Balosso, S; Battaglia, G; Carriero, G; Colciaghi, F; Finardi, A; Frasca, A; Locatelli, D; Nobili, P; Vezzani, A | 1 |
Cotel, MC; Edgar, DM; Jones, MW; McCarthy, AP; O'Neill, MJ; Phillips, KG; Tricklebank, M; Wafford, KA | 1 |
Aras, S; Cook, JM; Gill, KM; Grace, AA; Lodge, DJ | 1 |
Collingridge, GL; Cotel, MC; O'Neill, MJ; Sanderson, TM; Sher, E; Tricklebank, MD | 1 |
Cifelli, P; Gill, KM; Grace, AA; Valenti, O | 1 |
Doisy, ET; Jürgen Wenzel, H; Schwartzkroin, PA; Tschuluun, N | 1 |
Bahn, S; Cheng, TM; Collingridge, GL; Fitzjohn, SM; Guest, PC; Harris, LW; Holmes, E; Hradetzky, E; Lakics, V; Malik, N; O'Neill, MJ; Rahmoune, H; Sanderson, TM; Schoeffmann, S; Sher, E; Sherwood, JL; Tricklebank, MD; Tsang, TM | 1 |
Schwartzkroin, PA; Wenzel, HJ | 1 |
Belujon, P; Grace, AA; Patton, MH | 2 |
Asher, A; Lodge, DJ; Perez, SM; Shah, A | 1 |
Lodge, DJ; Shah, A | 1 |
Baraban, SC; Calcagnotto, ME; Paredes, MF | 1 |
Baraban, SC; Barbaro, NM; Smyth, MD | 1 |
Baraban, SC; Calcagnotto, ME | 2 |
Bigl, V; Rossner, S | 1 |
Bassanini, S; Battaglia, G; Cattabeni, F; Di Luca, M; Pagliardini, S; Saglietti, L; Setola, V | 1 |
Bassanini, S; Battaglia, G; Cattabeni, F; Di Luca, M; Gardoni, F; Pagliardini, S; Setola, V | 1 |
Feldon, J; Jongen-Rêlo, AL; Leng, A; Lüber, M; Pothuizen, HH; Weber, L | 1 |
Bae, YC; Cho, JH; Choi, BJ; Choi, IS; Jung, SC; Kim, JH; Lee, MG | 1 |
Gourevitch, R; Jay, TM; Krebs, MO; Le Pen, G; Rocher, C | 1 |
Cortez, MA; McKerlie, C; Serbanescu, I; Snead, OC | 1 |
Didriksen, M; Flagstad, P; Glenthøj, BY | 1 |
Arnfred, S; Cumming, P; Gjedde, A; Hansen, AK; Hemmingsen, R; Jelsing, J; Olsen, AK; Pakkenberg, B | 1 |
Corfas, G; Gierdalski, M; Juliano, SL; Sardi, SP | 1 |
Didriksen, M; Flagstad, P; Leist, M; Michael-Titus, AT; Penschuck, S | 1 |
Baraban, SC; Paredes, M; Pleasure, SJ | 1 |
Geyer, MA; Ghajarnia, M; Grace, AA; Jentsch, JD; Moore, H | 1 |
Baraban, SC; Berger, O; Li, G; Paredes, MF; Pleasure, SJ | 1 |
Gourevitch, R; Hazane, F; Hoareau, C; Jay, TM; Krebs, MO; Le Pen, G | 1 |
Bassanini, S; Battaglia, G; Caccia, S; Chimenti, S; Gagliardi, B; Guiso, G; Marchi, N; Noé, F; Ravizza, T; Rizzi, M; Vezzani, A | 1 |
Featherstone, RE; Fletcher, PJ; Kapur, S; Nobrega, JN; Rizos, Z | 1 |
Baraban, SC; Harrington, EP; Möddel, G; Najm, IM | 1 |
Chessel, A; Garcia, R; Krebs, MO; Le Pen, G; Léna, I | 1 |
Bassanini, S; Battaglia, G; Cipolla, M; Finardi, A; Hallene, K; Janigro, D; Santaguida, S | 1 |
Falsig, J; Geist, MA; Leist, M; Podhorna, J; Volbracht, C | 1 |
Juliano, SL; Schaefer, AW | 1 |
Dumas, RM; Fernandez, K; Haddad, RK; Vorhees, CV | 1 |
de Feo, MR; Mecarelli, O; Ricci, GF | 1 |
Lam, LK; Zhang, J | 1 |
Abcarian, H; Kako, H; Misumi, A; Nelson, RL; Nelson, TM; Rizk, S; Sky-Peck, H | 1 |
Alabaster, O; Nikula, KJ; Shivapurkar, N; Tanaka, T; Tang, ZC | 1 |
Hara, A; Mori, H; Nagao, M; Nakagama, H; Sugimura, T; Suzui, M; Ushijima, T; Yoshimi, N | 1 |
Germano, IM; Sperber, EF | 1 |
Koch, T; Korf, J; Talamini, LM; Ter Horst, GJ | 1 |
Avanzini, G; Battaglia, G; Cattabeni, F; Colacitti, C; Di Luca, M; Franceschetti, S; Sancini, G; Spreafico, R | 1 |
Baraban, SC; Ben-Ari, Y; Chevassus-au-Louis, N; Gaïarsa, JL | 1 |
Aloe, L; Angelucci, F; Fiore, M; Koch, T; Korf, J; Talamini, L | 1 |
Jacobs, KM; Kharazia, VN; Prince, DA | 1 |
Baraban, SC; Castro, PA; Cooper, EC; Lowenstein, DH | 1 |
Davies, P; Minger, SL | 2 |
Batshaw, ML; Hyman, SL; Mercugliano, M | 1 |
Ding, JL; Hee, PL; Lam, TJ | 1 |
Archer, T; Fredriksson, A; Jonsson, G; Lewander, T; Luthman, J; Söderberg, U; Sundström, E | 1 |
Fournie, JW; Hawkins, WE; Overstreet, RM; Walker, WW | 1 |
Abbracchio, MP; Balduini, W; Cattabeni, F; Cecchini, T; Cimino, M; Gazzanelli, GC; Lombardelli, G; Peruzzi, G | 1 |
9 review(s) available for methylazoxymethanol acetate and Disease Models, Animal
Article | Year |
---|---|
Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Hippocampus; Male; Methylazoxymethanol Acetate; Mice; Rats; Schizophrenia; Ventral Tegmental Area | 2020 |
Translating the MAM model of psychosis to humans.
Topics: Animals; Brain; Disease Models, Animal; Humans; Methylazoxymethanol Acetate; Psychotic Disorders | 2015 |
Developmental pathways of motor dysfunction.
Topics: Animals; Brain; Disease Models, Animal; Female; Guinea Pigs; Methylazoxymethanol Acetate; Mice; Motor Skills Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 2015 |
Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.
Topics: Adolescent; Animals; Brain; Disease Models, Animal; Dopamine; Humans; Methylazoxymethanol Acetate; Rats; Schizophrenia | 2016 |
Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.
Topics: Animals; Disease Models, Animal; Dopamine; Female; Gestational Age; Hippocampus; Humans; Methylazoxymethanol Acetate; Neural Pathways; Nucleic Acid Synthesis Inhibitors; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia; Signal Transduction | 2008 |
Are developmental dysplastic lesions epileptogenic?
Topics: Animals; Carcinogens; Disease Models, Animal; Epilepsy; Female; Humans; Malformations of Cortical Development; Methylazoxymethanol Acetate; Mice; Mice, Knockout; Phosphotransferases; Pregnancy; Rats; Tuberous Sclerosis | 2012 |
Amyloid precursor protein processing in vivo--insights from a chemically-induced constitutive overactivation of protein kinase C in Guinea pig brain.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Brain Diseases; Disease Models, Animal; Endopeptidases; Enzyme Activation; Female; Guinea Pigs; Isoenzymes; Methylazoxymethanol Acetate; Microcephaly; Mutation; Peptide Hydrolases; Pregnancy; Protein Kinase C; Protein Processing, Post-Translational | 2003 |
Cortical malformations and epilepsy: new insights from animal models.
Topics: Abnormalities, Drug-Induced; Animals; Cerebral Cortex; Disease Models, Animal; Epilepsy; Hippocampus; Humans; Methylazoxymethanol Acetate; Mice; Mice, Knockout; Mitosis; Mutation; Nervous System Malformations; Neural Conduction; Neural Pathways; Rats; Rats, Mutant Strains; Teratogens | 1999 |
Mechanisms underlying epileptogenesis in cortical malformations.
Topics: Abnormalities, Drug-Induced; Animals; Cerebral Cortex; Disease Models, Animal; Epilepsy; Humans; Methylazoxymethanol Acetate; Nucleic Acid Synthesis Inhibitors; Synaptic Transmission | 1999 |
137 other study(ies) available for methylazoxymethanol acetate and Disease Models, Animal
Article | Year |
---|---|
Nicotine Administration Normalizes Behavioral and Neurophysiological Perturbations in the MAM Rodent Model of Schizophrenia.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Hippocampus; Male; Methylazoxymethanol Acetate; Nicotine; Prepulse Inhibition; Rats; Rats, Sprague-Dawley; Schizophrenia; Self Medication; Ventral Tegmental Area | 2021 |
GABA
Topics: Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Hippocampus; Methylazoxymethanol Acetate; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2022 |
LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia.
Topics: Amino Acids, Dicarboxylic; Animals; Bridged Bicyclo Compounds; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Methylazoxymethanol Acetate; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Signal Transduction | 2022 |
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia.
Topics: Animals; Disease Models, Animal; Female; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Schizophrenia | 2022 |
Use of prepubertal environment enrichment to prevent dopamine dysregulation in a neurodevelopmental rat model of schizophrenia risk.
Topics: Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Female; Male; Methylazoxymethanol Acetate; Pregnancy; Rats; Schizophrenia | 2022 |
Congenital blindness does not protect against a schizophrenia-related phenotype in rodents.
Topics: Animals; Blindness; Corticosterone; Disease Models, Animal; Female; Male; Methylazoxymethanol Acetate; Phenotype; Rats; Rats, Sprague-Dawley; Rodentia; Schizophrenia | 2023 |
Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods.
Topics: Age Factors; Animals; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; Female; Hippocampus; Male; Maze Learning; Memory, Short-Term; Methylazoxymethanol Acetate; Neurotoxins; Rats; Rats, Wistar; Reward; Schizophrenia; Sexual Maturation | 2020 |
A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research.
Topics: Adult; Animals; Disease Models, Animal; Epigenesis, Genetic; Female; Hippocampus; Humans; Male; Methylazoxymethanol Acetate; MicroRNAs; Neurodevelopmental Disorders; Neurotoxins; Prefrontal Cortex; Pregnancy; Proto-Oncogene Mas; Rats; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia; Sequence Analysis, RNA; Transcription, Genetic; Translational Research, Biomedical | 2020 |
Memory deterioration based on the tobacco smoke exposure and methylazoxymethanol acetate administration vs. aripiprazole, olanzapine and enrichment environment conditions.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Cognition; Disease Models, Animal; Female; Male; Methylazoxymethanol Acetate; Morris Water Maze Test; Neurotoxins; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Spatial Memory; Tobacco Smoke Pollution; Treatment Outcome | 2020 |
Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.
Topics: Animals; Disease Models, Animal; Female; Male; Methylazoxymethanol Acetate; Neurotoxins; Oxytocin; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Schizophrenia; Schizophrenic Psychology; Social Behavior; Vocalization, Animal | 2020 |
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
Topics: Animals; Antipsychotic Agents; Brain; Cannabidiol; Cerebrovascular Circulation; Disease Models, Animal; Female; Gene Expression Regulation; Haloperidol; Magnetic Resonance Imaging; Male; Methylazoxymethanol Acetate; Models, Molecular; Molecular Dynamics Simulation; Pregnancy; Prenatal Exposure Delayed Effects; Puberty; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia | 2020 |
Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Gene Expression Profiling; Growth and Development; Hippocampus; Malnutrition; Methylazoxymethanol Acetate; Poly I-C; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia | 2020 |
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Female; Haloperidol; Lipid Metabolism; Male; Metabolome; Methylazoxymethanol Acetate; Olanzapine; Rats, Sprague-Dawley; Risperidone; Schizophrenia | 2020 |
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Disease Models, Animal; Female; Haloperidol; Intra-Abdominal Fat; Methylazoxymethanol Acetate; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Proteomics; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats.
Topics: Animals; Disease Models, Animal; Dopamine; Hippocampus; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Schizophrenia | 2021 |
Diminished excitatory synaptic transmission correlates with impaired spatial working memory in neurodevelopmental rodent models of schizophrenia.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Excitatory Postsynaptic Potentials; Female; Male; Memory, Short-Term; Methylazoxymethanol Acetate; Mice; Mice, Inbred C57BL; Neurodevelopmental Disorders; Prefrontal Cortex; Pregnancy; Pyramidal Cells; Schizophrenia; Schizophrenic Psychology; Social Isolation; Spatial Memory; Synaptic Transmission | 2021 |
Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.
Topics: Age Factors; Amino Acids; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Excitatory Amino Acid Agonists; Hippocampus; Male; Methylazoxymethanol Acetate; Neurotoxins; Rats; Receptors, Metabotropic Glutamate; Schizophrenia; Ventral Tegmental Area | 2021 |
Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Methylazoxymethanol Acetate; Rats; Schizophrenia; Thalamic Nuclei | 2021 |
Reduced risk aversion and impaired short-term memory in juvenile rats with malformation of cortical development.
Topics: Affect; Animals; Anxiety; Behavior, Animal; Brain; Cognition; Cues; Disease Models, Animal; Female; Hippocampus; Male; Malformations of Cortical Development; Maze Learning; Memory, Short-Term; Methylazoxymethanol Acetate; Motor Activity; Neurogenesis; Rats; Rats, Sprague-Dawley; Risk Reduction Behavior; Risk-Taking; Spatial Memory | 2021 |
Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia.
Topics: Adolescent; Adolescent Development; Animals; Azepines; Disease Models, Animal; Female; Gene Expression Regulation, Developmental; Humans; Long-Term Potentiation; Male; Methylazoxymethanol Acetate; Prefrontal Cortex; Proteomics; Rats; Recognition, Psychology; Schizophrenia; Sex Characteristics; Triazoles | 2021 |
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ketamine; Locomotion; Methamphetamine; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Schizophrenia; Self Administration | 2017 |
The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats.
Topics: Aging; Animals; Anxiety; Disease Models, Animal; Exploratory Behavior; Female; Hippocampus; Male; Methylazoxymethanol Acetate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Rats, Wistar; Rotarod Performance Test; Schizophrenia; Schizophrenic Psychology | 2017 |
Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; Cognition Disorders; Disease Models, Animal; Epigenesis, Genetic; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Female; Gene Expression Regulation, Developmental; In Vitro Techniques; Male; Methylazoxymethanol Acetate; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Pregnancy; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2017 |
MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
Topics: Animals; Attention; Cognition; Disease Models, Animal; Executive Function; Male; Methylazoxymethanol Acetate; Neurotoxins; Nootropic Agents; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Schizophrenia; Treatment Outcome | 2017 |
The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex: An Editorial Highlight for 'Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM
Topics: Animals; Disease Models, Animal; Epigenesis, Genetic; Female; Methylazoxymethanol Acetate; Neurotoxins; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia | 2017 |
Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
Topics: Action Potentials; Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Dopaminergic Neurons; Fear; Female; Learning Disabilities; Locomotion; Male; Methylazoxymethanol Acetate; Neurotoxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Schizophrenia; Time Factors; Ventral Tegmental Area | 2018 |
Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia.
Topics: Animals; Disease Models, Animal; Environment; Histones; Housing, Animal; Male; Methylazoxymethanol Acetate; Prefrontal Cortex; Random Allocation; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Sexual Maturation; Site-Specific DNA-Methyltransferase (Adenine-Specific) | 2018 |
Ablation of aberrant neurogenesis fails to attenuate cognitive deficit of chronically epileptic mice.
Topics: Animals; Bromodeoxyuridine; Cell Proliferation; Cognition Disorders; Disease Models, Animal; Doublecortin Domain Proteins; Green Fluorescent Proteins; Hippocampus; Homeodomain Proteins; Ki-67 Antigen; Male; Maze Learning; Methylazoxymethanol Acetate; Mice; Microtubule-Associated Proteins; Muscarinic Agonists; Neurogenesis; Neuropeptides; Pilocarpine; Proto-Oncogene Proteins c-fos; Status Epilepticus; Transduction, Genetic; Tumor Suppressor Proteins | 2018 |
Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
Topics: Age Factors; Animals; Carcinogens; Disease Models, Animal; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Glutamate Decarboxylase; Interpersonal Relations; Locomotion; Methylazoxymethanol Acetate; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Social Isolation; Statistics, Nonparametric | 2018 |
Therapeutic effect of perinatal exogenous melatonin on behavioral and histopathological changes and antioxidative enzymes in neonate mouse model of cortical malformation.
Topics: Animals; Animals, Newborn; Antioxidants; Carcinogens; Catalase; Disease Models, Animal; Exploratory Behavior; Female; Gene Expression Regulation, Developmental; Glutathione Peroxidase; Intermediate Filaments; Malformations of Cortical Development; Malondialdehyde; Maze Learning; Melatonin; Methylazoxymethanol Acetate; Mice; Mice, Inbred BALB C; Nitroprusside; Pregnancy; Prenatal Exposure Delayed Effects; Superoxide Dismutase; Tryptamines | 2018 |
α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.
Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Basolateral Nuclear Complex; Disease Models, Animal; Dopaminergic Neurons; Hippocampus; Male; Methylazoxymethanol Acetate; Random Allocation; Rats, Sprague-Dawley; Schizophrenia; Ventral Tegmental Area | 2018 |
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.
Topics: Animals; Brain; Disease Models, Animal; Gene Expression Regulation, Developmental; In Situ Hybridization; Male; Methylazoxymethanol Acetate; Random Allocation; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; RNA, Messenger; Schizophrenia | 2018 |
Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.
Topics: Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Spines; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; Glycogen Synthase Kinase 3 beta; Learning Disabilities; Methylazoxymethanol Acetate; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Schizophrenia; Tissue Culture Techniques | 2018 |
Sub-circuit alterations in dorsal hippocampus structure and function after global neurodevelopmental insult.
Topics: Animals; Disease Models, Animal; Epilepsy; Female; Hippocampus; Male; Membrane Potentials; Methylazoxymethanol Acetate; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Long-Evans; Schizophrenia; Synapses | 2018 |
Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypertrophy; Lateral Ventricles; Male; Methylazoxymethanol Acetate; Mice; Mice, Inbred C57BL; Motor Activity; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Schizophrenia; Schizophrenic Psychology; Sex Characteristics; Social Behavior; Transcriptome | 2018 |
State-dependent effects of the D
Topics: Animals; Apomorphine; Aripiprazole; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopaminergic Neurons; Electroencephalography; Haloperidol; Male; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Ventral Tegmental Area | 2019 |
Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function.
Topics: Animals; Auditory Perception; Disease Models, Animal; Fear; Female; Hippocampus; Long-Term Potentiation; Male; Memory; Methylazoxymethanol Acetate; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Proteome; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Sex Characteristics | 2019 |
Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats.
Topics: Animals; Disease Models, Animal; Female; Male; Methylazoxymethanol Acetate; Pregnancy; Rats; Schizophrenia; Social Behavior; Ultrasonics; Vocalization, Animal | 2019 |
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Topics: Amides; Animals; Arachidonic Acids; Cannabidiol; Disease Models, Animal; Endocannabinoids; Ethanolamines; Female; Glycerides; Hippocampus; Interpersonal Relations; Male; Methylazoxymethanol Acetate; Motor Activity; Oleic Acids; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Puberty; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Recognition, Psychology; RNA, Messenger; Schizophrenia | 2019 |
Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats.
Topics: Amphetamine; Animals; Behavior, Animal; Disease Models, Animal; Estrous Cycle; Female; Hippocampus; Methylazoxymethanol Acetate; Parvalbumins; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Schizophrenia; Sensory Gating | 2019 |
Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Clozapine; Disease Models, Animal; Female; Haloperidol; Hippocampus; Methylazoxymethanol Acetate; Mice; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Risperidone; Schizophrenia | 2019 |
Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Methylazoxymethanol Acetate; Nicotine; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Schizophrenia; Self Administration; Sucrose | 2020 |
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats.
Topics: Animals; Behavior Observation Techniques; Cerebrovascular Circulation; Circle of Willis; Disease Models, Animal; Dronabinol; Female; Hippocampus; Humans; Magnetic Resonance Angiography; Male; Methylazoxymethanol Acetate; Neurogenesis; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia; Sensorimotor Cortex | 2019 |
Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model.
Topics: Animals; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Methylazoxymethanol Acetate; Neuroprotective Agents; Nitric Oxide Synthase Type I; Peptides; Pilocarpine; Pregnancy; Protein Binding; Random Allocation; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2019 |
The MAM rodent model of schizophrenia.
Topics: Animals; Brain; Clinical Protocols; Disease Models, Animal; Female; Fetal Development; Male; Methylazoxymethanol Acetate; Neurotoxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Schizophrenia | 2013 |
Altered migratory behavior of interneurons in a model of cortical dysplasia: the influence of elevated GABAA activity.
Topics: Animals; Blotting, Western; Cell Movement; Disease Models, Animal; Ferrets; GABA-A Receptor Antagonists; Interneurons; K Cl- Cotransporters; Malformations of Cortical Development; Methylazoxymethanol Acetate; Neocortex; Receptors, GABA-A; Symporters; Tissue Culture Techniques; Video Recording | 2014 |
A sensitive period for GABAergic interneurons in the dentate gyrus in modulating sensorimotor gating.
Topics: Age Factors; Animals; Behavior, Animal; Critical Period, Psychological; Dendrites; Dentate Gyrus; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin-Like Kinases; Drug Interactions; Environment; GABA Agonists; GABAergic Neurons; Inhibition, Psychological; Interneurons; Intracellular Signaling Peptides and Proteins; Male; Methylazoxymethanol Acetate; Mice; Mice, Inbred C57BL; Microinjections; Microtubule-Associated Proteins; Muscimol; Neurogenesis; Neuropeptides; Prefrontal Cortex; Protein Serine-Threonine Kinases; Schizophrenia; Sensory Gating | 2013 |
Fine-tuning of neurogenesis is essential for the evolutionary expansion of the cerebral cortex.
Topics: Animals; Animals, Newborn; Biological Evolution; Disease Models, Animal; Eye Proteins; Ferrets; Homeodomain Proteins; Lissencephaly; Methylazoxymethanol Acetate; Mice; Neural Stem Cells; Neurogenesis; Neuroglia; Neurons; Paired Box Transcription Factors; Parietal Lobe; PAX6 Transcription Factor; Repressor Proteins; Stem Cell Niche; Temporal Lobe | 2015 |
Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia.
Topics: Action Potentials; Amphetamine; Animals; Disease Models, Animal; Dopaminergic Neurons; Female; Hippocampus; Interneurons; Male; Median Eminence; Methylazoxymethanol Acetate; Motor Activity; Rats; Schizophrenia | 2013 |
Targeted disruption of layer 4 during development increases GABAA receptor neurotransmission in the neocortex.
Topics: Animals; Disease Models, Animal; Female; Ferrets; Inhibitory Postsynaptic Potentials; Malformations of Cortical Development; Methylazoxymethanol Acetate; Miniature Postsynaptic Potentials; Neocortex; Pregnancy; Protein Subunits; Pyramidal Cells; Receptors, GABA-A; Teratogens | 2014 |
Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
Topics: Allosteric Regulation; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Diazepam; Disease Models, Animal; Dopamine; Dopamine Agents; Dopaminergic Neurons; Drug Interactions; Female; GABA Agonists; Haloperidol; Hippocampus; Imidazoles; Locomotion; Male; Methylazoxymethanol Acetate; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Schizophrenia; Sodium Chloride; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2014 |
An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
Topics: Action Potentials; Amphetamine; Animals; Disease Models, Animal; Dopamine; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Hippocampus; Methylazoxymethanol Acetate; Motor Activity; Neural Pathways; Parvalbumins; Pedunculopontine Tegmental Nucleus; Rats, Sprague-Dawley; Schizophrenia; Sexual Maturation; Ventral Tegmental Area | 2014 |
Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model.
Topics: Age Factors; Analysis of Variance; Animals; Cell Death; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Methylazoxymethanol Acetate; Neurons; Neurotoxins; Parvalbumins; Rats; Receptors, Neurokinin-1; Schizophrenia | 2014 |
Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia.
Topics: Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Estrous Cycle; Female; Humans; Male; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia; Signal Transduction; Vaginal Smears | 2014 |
Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.
Topics: Action Potentials; Animals; Disease Models, Animal; Dopaminergic Neurons; Hippocampus; Humans; Male; Methylazoxymethanol Acetate; Neurotoxins; Rats; Rats, Sprague-Dawley; Schizophrenia; Treatment Outcome; Vagus Nerve Stimulation | 2014 |
Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Dentate Gyrus; Diphtheria Toxin; Disease Models, Animal; Flavones; Gene Knockdown Techniques; Hippocampus; Housing, Animal; Male; Memory Disorders; Methylazoxymethanol Acetate; Mice; Mice, Transgenic; Neurogenesis; Presenilin-1; Social Behavior | 2014 |
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Topics: Amphetamine; Animals; Attention; Benzoxazines; Cannabinoids; Central Nervous System Stimulants; Disease Models, Animal; Dopaminergic Neurons; Executive Function; Female; Male; Methylazoxymethanol Acetate; Morpholines; Motor Activity; Naphthalenes; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Ventral Tegmental Area | 2014 |
Standard dose valproic acid does not cause additional cognitive impact in a rodent model of intractable epilepsy.
Topics: Animals; Animals, Newborn; Anticonvulsants; Cognition; Cognition Disorders; Disease Models, Animal; Epilepsy; Female; Flurothyl; Hippocampus; Malformations of Cortical Development; Maze Learning; Methylazoxymethanol Acetate; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats, Sprague-Dawley; Seizures; Survival Analysis; Valproic Acid | 2015 |
Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia.
Topics: Animals; Anxiety; Disease Models, Animal; Hippocampus; Male; Memory, Short-Term; Methylazoxymethanol Acetate; Rats; Schizophrenia; Spatial Memory | 2015 |
Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Brain Waves; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Excitatory Amino Acid Antagonists; Female; Male; Methylazoxymethanol Acetate; Neurotoxins; Nucleus Accumbens; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia | 2015 |
[MAM-E17 schizophrenia rat model].
Topics: Animals; Behavior, Animal; Brain; Cognition; Disease Models, Animal; Frontal Lobe; Hippocampus; Limbic System; Locomotion; Methylazoxymethanol Acetate; Movement Disorders; Neurotoxins; Rats; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2015 |
MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function.
Topics: Amphetamine; Animals; Conditioning, Classical; Disease Models, Animal; Dopamine; Executive Function; Learning; Male; Methylazoxymethanol Acetate; Motivation; Nucleus Accumbens; Rats, Sprague-Dawley; Reward; Schizophrenia; Schizophrenic Psychology | 2015 |
Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.
Topics: Animals; Disease Models, Animal; DNA Methylation; Dopaminergic Neurons; Female; Hippocampus; Male; Methylation; Methylazoxymethanol Acetate; Parvalbumins; Phenotype; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Schizophrenia; Transcription Factors; Ventral Tegmental Area | 2016 |
Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia.
Topics: Acetylation; Animals; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Histone Deacetylase 2; Histones; Male; Methylazoxymethanol Acetate; Prefrontal Cortex; Rats; Schizophrenia; Sensory Gating; Valproic Acid | 2015 |
Biochemical and cognitive impairments observed in animal models of schizophrenia induced by prenatal stress paradigm or methylazoxymethanol acetate administration.
Topics: Analysis of Variance; Animals; Brain-Derived Neurotrophic Factor; Cognition Disorders; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Female; Gestational Age; Male; Maze Learning; Methylazoxymethanol Acetate; Motor Activity; Neurotoxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia | 2015 |
Dopamine System Dysregulation and the Pathophysiology of Schizophrenia: Insights From the Methylazoxymethanol Acetate Model.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Humans; Methylazoxymethanol Acetate; Neurons; Rats; Schizophrenia | 2017 |
Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.
Topics: Action Potentials; Administration, Oral; Amygdala; Animals; Animals, Newborn; Anti-Anxiety Agents; Anxiety; Conditioning, Psychological; Diazepam; Disease Models, Animal; Fear; Female; Hippocampus; Male; Maze Learning; Methylazoxymethanol Acetate; Neurons; Neurotoxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia | 2016 |
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats.
Topics: Alcohol Drinking; Animals; Behavior, Animal; Disease Models, Animal; Female; Male; Methamphetamine; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia; Sex Characteristics | 2017 |
Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Diazepam; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Female; Gestational Age; Hippocampus; Interneurons; Methylazoxymethanol Acetate; Parvalbumins; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sexual Maturation | 2016 |
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
Topics: Animals; Behavior, Animal; Biomarkers; Brain; Decision Making; Diffusion Tensor Imaging; Disease Models, Animal; Female; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylazoxymethanol Acetate; Multimodal Imaging; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reversal Learning; Reward; Schizophrenia; Schizophrenic Psychology | 2017 |
Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Executive Function; Female; Hippocampus; Hyperkinesis; Male; Memory Disorders; Methylazoxymethanol Acetate; Prefrontal Cortex; Pregnancy; Rats; Rats, Long-Evans; Schizophrenia; Spatial Memory | 2016 |
Prenatal transplantation of epidermal neural crest stem cells in malformation of cortical development mouse model.
Topics: Animals; Calcium-Binding Proteins; Cell- and Tissue-Based Therapy; Cells, Cultured; Cerebral Cortex; Chemokine CXCL12; Chick Embryo; Corpus Callosum; Disease Models, Animal; DNA-Binding Proteins; Doublecortin Domain Proteins; Doublecortin Protein; Epithelial Cells; Female; Glial Fibrillary Acidic Protein; Hair Follicle; Homeodomain Proteins; Methylazoxymethanol Acetate; Mice; Mice, Inbred BALB C; Microfilament Proteins; Microtubule-Associated Proteins; Nerve Tissue Proteins; Nestin; Neural Crest; Neural Stem Cells; Neurogenesis; Neuropeptides; Nuclear Proteins; Pregnancy; Receptors, CXCR4; Tissue Culture Techniques | 2017 |
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
Topics: Animals; Bipolar Disorder; Cohort Studies; CpG Islands; Depressive Disorder, Major; Disease Models, Animal; DNA Methylation; Endocannabinoids; Female; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Male; Methylazoxymethanol Acetate; Middle Aged; Prefrontal Cortex; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Schizophrenia | 2017 |
Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia.
Topics: Amino Acids, Dicarboxylic; Animals; Brain; Bridged Bicyclo Compounds; Cognition; Cognition Disorders; Disease Models, Animal; Learning; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2017 |
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals.
Topics: Acetylation; Animals; Antipsychotic Agents; Brain; Cannabinoid Receptor Antagonists; Disease Models, Animal; Epigenesis, Genetic; Gene Expression Regulation, Developmental; Gestational Age; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Methylazoxymethanol Acetate; Mice, Inbred C57BL; Neural Cell Adhesion Molecules; Neurogenesis; Neurons; Protein Processing, Post-Translational; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Schizophrenia; Signal Transduction; SOXB1 Transcription Factors; Time Factors | 2018 |
Combined effects of prenatal inhibition of vasculogenesis and neurogenesis on rat brain development.
Topics: Aging; Animals; Animals, Newborn; Blood Vessels; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Disease Models, Animal; Gliosis; Hippocampus; Malformations of Cortical Development; Methylazoxymethanol Acetate; Mossy Fibers, Hippocampal; Neovascularization, Physiologic; Nervous System; Neurogenesis; Rats; Rats, Sprague-Dawley; Thalidomide | 2008 |
The ALS/PDC syndrome of Guam and the cycad hypothesis.
Topics: alpha-Synuclein; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Bacterial Toxins; Causality; Cyanobacteria Toxins; Cycas; Dementia; Disease Models, Animal; Epidemiologic Research Design; Epidemiologic Studies; Flour; Guam; Hazardous Substances; Humans; Incidence; Indonesia; Japan; Marine Toxins; Methylazoxymethanol Acetate; Microcystins; Nerve Degeneration; Parkinsonian Disorders; Plant Extracts; Syndrome; Tauopathies | 2009 |
A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Biological Clocks; Conditioning, Psychological; Disease Models, Animal; Electroencephalography; Evoked Potentials; Fear; Female; Glutamate Decarboxylase; Hippocampus; Interneurons; Male; Methylazoxymethanol Acetate; Neural Inhibition; Neurotoxins; Parvalbumins; Prefrontal Cortex; Pregnancy; Rats; Schizophrenia; Spectrum Analysis | 2009 |
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia.
Topics: Animals; Brain; Disease Models, Animal; Female; Hyperkinesis; Memory, Short-Term; Methylazoxymethanol Acetate; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia; Schizophrenic Psychology; Sensory Gating | 2009 |
Role of cortical dysplasia in epileptogenesis following prolonged febrile seizure.
Topics: Animals; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Hippocampus; Humans; Malformations of Cortical Development; Methylazoxymethanol Acetate; Mossy Fibers, Hippocampal; Rats; Rats, Sprague-Dawley; Sclerosis; Seizures, Febrile; Synapses | 2010 |
Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Female; Hyperkinesis; Methylazoxymethanol Acetate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Schizophrenia | 2011 |
Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
Topics: Action Potentials; Amphetamine; Animals; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Male; Methylazoxymethanol Acetate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Schizophrenia; Ventral Tegmental Area | 2012 |
Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Malformations of Cortical Development; Methylazoxymethanol Acetate; Neurons; Pilocarpine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Status Epilepticus | 2011 |
Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia.
Topics: Animals; Biphenyl Compounds; Brain Waves; Cerebral Cortex; Cross-Over Studies; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Male; Methylazoxymethanol Acetate; Pregnancy; Propionates; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2012 |
A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
Topics: Allosteric Regulation; Amphetamine; Animals; Benzodiazepines; Diazepam; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Female; GABA Agonists; Hippocampus; Humans; Hyperkinesis; Imidazoles; Male; Methylazoxymethanol Acetate; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Schizophrenia; Ventral Tegmental Area | 2011 |
Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia.
Topics: Animals; Disease Models, Animal; Excitatory Postsynaptic Potentials; Female; Hippocampus; Male; Methylazoxymethanol Acetate; Neuronal Plasticity; Organ Culture Techniques; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia; Synaptic Transmission | 2012 |
Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.
Topics: Action Potentials; Animals; Animals, Newborn; Antipsychotic Agents; Cell Polarity; Disease Models, Animal; Dopamine; Female; Inhibitory Postsynaptic Potentials; Male; Methylazoxymethanol Acetate; Neural Inhibition; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Reaction Time; Schizophrenia; Ventral Tegmental Area | 2011 |
Initiation of epileptiform activity in a rat model of periventricular nodular heterotopia.
Topics: Action Potentials; Animals; Disease Models, Animal; Epilepsy; Female; Hippocampus; In Vitro Techniques; Lysine; Male; Methylazoxymethanol Acetate; Neocortex; Neurons; Periventricular Nodular Heterotopia; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Teratogens | 2011 |
The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.
Topics: Animals; Disease Models, Animal; Female; Frontal Lobe; Gene Expression Regulation; Hippocampus; Humans; Male; Metabolomics; Methylazoxymethanol Acetate; Pregnancy; Prenatal Exposure Delayed Effects; Proteomics; Rats; Schizophrenia; Synaptic Transmission | 2012 |
Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Female; Hippocampus; Long-Term Potentiation; Male; Methylazoxymethanol Acetate; Prefrontal Cortex; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia; Sulpiride | 2013 |
Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.
Topics: Action Potentials; Amphetamine; Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Deep Brain Stimulation; Disease Models, Animal; Dopaminergic Neurons; Female; Hippocampus; Hyperkinesis; Male; Mental Disorders; Methylazoxymethanol Acetate; Neurotoxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Schizophrenia; Ventral Tegmental Area | 2013 |
Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Hippocampus; Male; Methylazoxymethanol Acetate; Neural Pathways; Neuronal Plasticity; Neurons; Neurotoxins; Nucleus Accumbens; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Schizophrenia; Synapses | 2014 |
A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.
Topics: Amphetamine; Analysis of Variance; Animals; Chondroitin ABC Lyase; Chondroitin Sulfate Proteoglycans; Disease Models, Animal; Dopamine; Hippocampus; Immunohistochemistry; Interneurons; Male; Methylazoxymethanol Acetate; Parvalbumins; Rats; Rats, Sprague-Dawley; Schizophrenia | 2013 |
Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy.
Topics: Animals; Carrier Proteins; Choristoma; Disease Models, Animal; Epilepsy; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Male; Membrane Proteins; Membrane Transport Proteins; Methylazoxymethanol Acetate; Nervous System Malformations; Neural Inhibition; Neurons; Organic Anion Transporters; Patch-Clamp Techniques; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Synapses | 2002 |
Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia.
Topics: 4-Aminopyridine; Action Potentials; Animals; Animals, Newborn; Anticonvulsants; Carbamazepine; Disease Models, Animal; Electroencephalography; Epilepsy; Ethosuximide; Female; Hippocampus; In Vitro Techniques; Lamotrigine; Methylazoxymethanol Acetate; Phenobarbital; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Triazines; Valproic Acid | 2002 |
An examination of calcium current function on heterotopic neurons in hippocampal slices from rats exposed to methylazoxymethanol.
Topics: Animals; Calcium; Calcium Channels; Choristoma; Disease Models, Animal; Electrophysiology; Epilepsy; Female; Hippocampus; Humans; In Vitro Techniques; Methylazoxymethanol Acetate; Nervous System Malformations; Neurons; Patch-Clamp Techniques; Potassium Channels; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Teratogens | 2003 |
Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment.
Topics: Animals; Brain Diseases; Bromodeoxyuridine; Cerebral Cortex; Choristoma; Disease Models, Animal; Female; Methylazoxymethanol Acetate; Microscopy, Confocal; Morphogenesis; Neurons; Phenotype; Pregnancy; Rats; Rats, Sprague-Dawley | 2003 |
The NMDA receptor complex is altered in an animal model of human cerebral heterotopia.
Topics: Animals; Animals, Newborn; Autoradiography; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; Cell Membrane; Cerebral Cortex; Choristoma; Cloning, Molecular; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Hippocampus; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; Matched-Pair Analysis; Membrane Proteins; Methylazoxymethanol Acetate; Microscopy, Confocal; Nerve Tissue Proteins; Peptide Fragments; Phosphorylation; Pregnancy; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Subcellular Fractions | 2003 |
The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Avoidance Learning; Behavior, Animal; Body Weight; Brain; Cognition; Disease Models, Animal; Dose-Response Relationship, Radiation; Embryo, Mammalian; Emotions; Female; Inhibition, Psychological; Male; Methylazoxymethanol Acetate; Motor Activity; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Protein Synthesis Inhibitors; Rats; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Sex Factors | 2004 |
Excitability of CA1 neurons in the model of malformation-associated epilepsy.
Topics: Animals; Bicuculline; Disease Models, Animal; Dose-Response Relationship, Radiation; Electric Stimulation; Epilepsy; Evoked Potentials; Female; GABA Antagonists; Hippocampus; Male; Methylazoxymethanol Acetate; Neurons; Potassium Acetate; Pregnancy; Rats; Rats, Sprague-Dawley | 2004 |
Working memory deficits in adult rats after prenatal disruption of neurogenesis.
Topics: Abnormalities, Drug-Induced; Animals; Disease Models, Animal; Drug Administration Schedule; Female; Hippocampus; Male; Maze Learning; Memory Disorders; Methylazoxymethanol Acetate; Organ Size; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Time Factors | 2004 |
Refractory atypical absence seizures in rat: a two hit model.
Topics: Animals; Anticholesteremic Agents; Brain; Disease Models, Animal; Drug Resistance; Electroencephalography; Epilepsy, Absence; Female; Methylazoxymethanol Acetate; Pregnancy; Prenatal Exposure Delayed Effects; Protein Synthesis Inhibitors; Rats; Rats, Long-Evans; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2004 |
Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia.
Topics: Animals; Association Learning; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Exploratory Behavior; Female; Maze Learning; Methylazoxymethanol Acetate; Nervous System; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Rats; Rats, Wistar; Recognition, Psychology; Reversal Learning; Schizophrenia; Swimming; Teratogens | 2005 |
A volumetric screening procedure for the Göttingen minipig brain.
Topics: Algorithms; Anatomy, Cross-Sectional; Animals; Brain; Cell Count; Disease Models, Animal; Female; Methylazoxymethanol Acetate; Nervous System Malformations; Pilot Projects; Pregnancy; Prenatal Exposure Delayed Effects; Swine; Swine, Miniature; Teratogens | 2005 |
Prolonged NMDA-mediated responses, altered ifenprodil sensitivity, and epileptiform-like events in the malformed hippocampus of methylazoxymethanol exposed rats.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Methylazoxymethanol Acetate; N-Methylaspartate; Patch-Clamp Techniques; Piperidines; Rats | 2005 |
Endogenous neuregulin restores radial glia in a (ferret) model of cortical dysplasia.
Topics: Animals; Animals, Newborn; Cerebral Cortex; Disease Models, Animal; Female; Ferrets; In Vitro Techniques; Methylazoxymethanol Acetate; Neuregulins; Neuroglia; Pregnancy; Prenatal Exposure Delayed Effects; Teratogens | 2005 |
Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Female; Gene Expression; Hippocampus; Immunohistochemistry; Methylazoxymethanol Acetate; Motor Activity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Time Factors | 2006 |
Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia.
Topics: Animals; Animals, Newborn; Cell Differentiation; Cell Movement; Cell Proliferation; Cerebral Cortex; Choristoma; Disease Models, Animal; Epilepsy; Female; Hippocampus; Methylazoxymethanol Acetate; Nervous System Malformations; Neuroglia; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Stem Cells; Teratogens | 2006 |
A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Methylazoxymethanol Acetate; Neurons; Neurotoxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred F344; Schizophrenia | 2006 |
Stromal-derived factor-1 (CXCL12) regulates laminar position of Cajal-Retzius cells in normal and dysplastic brains.
Topics: Animals; Cell Differentiation; Cell Movement; Cerebral Cortex; Chemokine CXCL12; Chemokines, CXC; Disease Models, Animal; Methylazoxymethanol Acetate; Nervous System Malformations; Neurons; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Stem Cells; Teratogens | 2006 |
Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Brain; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Inhibition, Psychological; Interpersonal Relations; Maze Learning; Methylazoxymethanol Acetate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Psychotic Disorders; Rats; Recognition, Psychology; Reflex, Startle; Time Factors | 2006 |
Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development.
Topics: Animals; Anticonvulsants; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Capillary Permeability; Choristoma; Disease Models, Animal; Drug Resistance; Endothelial Cells; Epilepsy; Female; Hippocampus; Male; Matched-Pair Analysis; Methylazoxymethanol Acetate; Ondansetron; Pregnancy; Rats; RNA, Messenger; Seizures; Serum Albumin | 2006 |
Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
Topics: Animals; Atrophy; Brain; Brain Damage, Chronic; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Female; Learning Disabilities; Male; Methylazoxymethanol Acetate; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Rats; Reinforcement, Psychology; Schizophrenia; Teratogens | 2007 |
Altered glutamate receptor - transporter expression and spontaneous seizures in rats exposed to methylazoxymethanol in utero.
Topics: Amino Acid Transport System X-AG; Amygdala; Animals; Cerebral Cortex; Choristoma; Disease Models, Animal; Electrodes, Implanted; Electroencephalography; Female; Hippocampus; Immunohistochemistry; Maternal-Fetal Exchange; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Seizures; Teratogens; Vesicular Glutamate Transport Protein 2 | 2007 |
Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Male; Methylazoxymethanol Acetate; Microdialysis; Motor Activity; Norepinephrine; Nucleus Accumbens; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2007 |
Early cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanol.
Topics: Abnormalities, Drug-Induced; Animals; Aquaporin 1; Brain; Cerebral Arteries; Cerebral Cortex; Disease Models, Animal; Female; Methylazoxymethanol Acetate; Neovascularization, Physiologic; Nervous System Malformations; Neurotoxins; Pokeweed Mitogens; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Teratogens; Vascular Endothelial Growth Factor A | 2007 |
Wide spectrum modulation by KP-544 in models relevant for neuronal survival.
Topics: Animals; Astrocytes; Cell Death; Cell Survival; Cerebellum; Cyclohexanols; Disease Models, Animal; Drug Synergism; Female; Male; Methylazoxymethanol Acetate; Nerve Growth Factor; Neurites; Neurons; Neuroprotective Agents; Neurotoxins; PC12 Cells; Pregnancy; Pyrimidines; Rats; Schizophrenia | 2007 |
Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.
Topics: Action Potentials; Animals; Disease Models, Animal; Dopamine; Hippocampus; Male; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Schizophrenia | 2007 |
Migration of transplanted neural progenitor cells in a ferret model of cortical dysplasia.
Topics: Amino Acids; Analysis of Variance; Animals; Animals, Newborn; Cell Culture Techniques; Cell Movement; Cell Proliferation; Disease Models, Animal; Embryo, Mammalian; Female; Ferrets; Malformations of Cortical Development; Methylazoxymethanol Acetate; Mice; Nerve Tissue Proteins; Neurons; Organ Culture Techniques; Pregnancy; Prenatal Exposure Delayed Effects; Stem Cell Transplantation; Stem Cells | 2008 |
Pervasive hyperactivity and long-term learning impairments in rats with induced micrencephaly from prenatal exposure to methylazoxymethanol.
Topics: Animals; Azo Compounds; Body Weight; Brain; Disease Models, Animal; Female; Humans; Hyperkinesis; Intellectual Disability; Learning Disabilities; Male; Methylazoxymethanol Acetate; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Spatial Behavior | 1984 |
Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate.
Topics: Age Factors; Animals; Bicuculline; Body Weight; Brain; Disease Models, Animal; Female; Humans; Infant, Newborn; Kainic Acid; Maternal-Fetal Exchange; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Wistar; Seizures | 1995 |
Colonoscopic colostomy model in rats for colon tumorigenesis studies.
Topics: 1,2-Dimethylhydrazine; Animals; Colonic Neoplasms; Colonoscopy; Colostomy; Dimethylhydrazines; Disease Models, Animal; Male; Methylazoxymethanol Acetate; Rats; Rats, Inbred F344 | 1994 |
The effect of dietary selenium deficiency on acute colorectal mucosal nucleotoxicity induced by several carcinogens in the rodent.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Colorectal Neoplasms; Deficiency Diseases; Disease Models, Animal; Intestinal Mucosa; Male; Methylazoxymethanol Acetate; Mitosis; Monomethylhydrazine; Rats; Rats, Sprague-Dawley; Selenium; Tumor Stem Cell Assay | 1996 |
Absence of p53 gene mutations in rat colon carcinomas induced through the synergistic interaction between methylazoxymethanol and X-irradiation.
Topics: Adenocarcinoma; Animals; Carcinogens; Colonic Neoplasms; Disease Models, Animal; Immunohistochemistry; Male; Methylazoxymethanol Acetate; Neoplasms, Radiation-Induced; Point Mutation; Rats; Tumor Suppressor Protein p53; Whole-Body Irradiation | 1997 |
No involvement of APC gene mutations in ulcerative colitis-associated rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate.
Topics: Animals; Anthraquinones; Base Sequence; Carcinogens; Colitis, Ulcerative; Colonic Neoplasms; Disease Models, Animal; DNA Primers; Genes, APC; Genes, ras; Humans; Male; Methylazoxymethanol Acetate; Mutagenesis; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Rats; Rats, Inbred F344 | 1997 |
Transplacentally induced neuronal migration disorders: an animal model for the study of the epilepsies.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Brain Mapping; Cell Movement; Disease Models, Animal; Electroencephalography; Epilepsy; Female; Gestational Age; Hippocampus; Litter Size; Maternal-Fetal Exchange; Methylazoxymethanol Acetate; Neurons; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Seizures | 1998 |
Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia.
Topics: Animals; Disease Models, Animal; Entorhinal Cortex; Female; Frontal Lobe; Gestational Age; Gyrus Cinguli; Hippocampus; Immunohistochemistry; Isoenzymes; Male; Methylazoxymethanol Acetate; Occipital Lobe; Pregnancy; Prenatal Exposure Delayed Effects; Protein Kinase C; Rats; Rats, Wistar; Schizophrenia | 1998 |
Altered connections between neocortical and heterotopic areas in methylazoxymethanol-treated rat.
Topics: Animals; Axonal Transport; Brain; Brain Diseases; Choristoma; Disease Models, Animal; Female; Functional Laterality; Gestational Age; Humans; Methylazoxymethanol Acetate; Neocortex; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Teratogens | 1998 |
Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Brain; Disease Models, Animal; Exploratory Behavior; Female; Methylazoxymethanol Acetate; Nerve Growth Factors; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Social Behavior; Substance P | 1999 |
Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy.
Topics: 4-Aminopyridine; Action Potentials; Animals; Cerebral Cortex; Choristoma; Delayed Rectifier Potassium Channels; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Female; Hippocampus; Immunohistochemistry; In Situ Hybridization; In Vitro Techniques; Methylazoxymethanol Acetate; Patch-Clamp Techniques; Potassium; Potassium Channels; Potassium Channels, Voltage-Gated; Pregnancy; Prenatal Exposure Delayed Effects; Pyramidal Cells; Rats; RNA, Messenger; Shab Potassium Channels; Shal Potassium Channels; Somatosensory Cortex; Tetraethylammonium | 2001 |
Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. II. Neurochemical analysis.
Topics: Acetylcholinesterase; Aging; Alzheimer Disease; Animals; Brain; Cerebral Cortex; Choline O-Acetyltransferase; Disease Models, Animal; Female; Fetus; Gestational Age; Methylazoxymethanol Acetate; Neurons; Pregnancy; Prosencephalon; Rats; Rats, Inbred Strains; Somatostatin | 1992 |
Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. I. Morphometric analysis.
Topics: Acetylcholine; Aging; Alzheimer Disease; Animals; Cerebral Cortex; Disease Models, Animal; Female; Fetus; Gestational Age; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; Male; Methylazoxymethanol Acetate; Neurons; Pregnancy; Prosencephalon; Rats; Rats, Inbred Strains | 1992 |
Behavioral deficits in rats with minimal cortical hypoplasia induced by methylazoxymethanol acetate.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Azo Compounds; Brain Chemistry; Cerebral Cortex; Disease Models, Animal; Female; Learning Disabilities; Methylazoxymethanol Acetate; Microcephaly; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains | 1990 |
Differential susceptibility of a fish, tilapia Oreochromis mossambicus (Teleostei, Cichlidae) to hepatocarcinogenesis by diethylnitrosamine and methylazoxymethanol acetate.
Topics: Animals; Azo Compounds; Cells, Cultured; Diethylnitrosamine; Disease Models, Animal; Female; Fish Diseases; gamma-Glutamyltransferase; Liver Neoplasms, Experimental; Male; Methylazoxymethanol Acetate; Perciformes; Tyrosine Transaminase | 1989 |
Prenatal methylazoxymethanol treatment potentiates d-amphetamine- and methylphenidate-induced motor activity in male and female rats.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Azo Compounds; Dextroamphetamine; Disease Models, Animal; Drug Synergism; Female; Fetus; Male; Methylazoxymethanol Acetate; Methylphenidate; Motor Activity; Rats; Receptors, Dopamine | 1988 |
Intraocular neoplasms induced by methylazoxymethanol acetate in Japanese medaka (Oryzias latipes).
Topics: Age Factors; Animals; Azo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Neoplasms; Fishes; Methylazoxymethanol Acetate; Neuroectodermal Tumors, Primitive, Peripheral; Retinoblastoma | 1986 |
Microencephalic rats as a model for cognitive disorders.
Topics: Animals; Azo Compounds; Cognition Disorders; Disease Models, Animal; Female; Gestational Age; Learning Disabilities; Methylazoxymethanol Acetate; Microcephaly; Motor Activity; Pregnancy; Rats; Reflex | 1986 |